US Equity
BMRN
— BIOMARIN PHARMACEUTICAL INC.BioMarin Pharmaceutical is a biotechnology company focused on developing and commercializing therapies for rare genetic diseases, including enzyme replacement therapies and gene therapies.
💰 Market cap: $11.65B📍 770 Lindaro Street, SAN RAFAEL, CA, 94901 US🏷️ Pharmaceuticals💵 Previous close: $59.33🔢 6,730 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $59.33 |
| 2026-07-23 | $58.87 |
| 2026-07-22 | $58.40 |
| 2026-07-21 | $59.21 |
| 2026-07-20 | $59.11 |
| 2026-07-17 | $59.59 |
| 2026-07-16 | $60.00 |
| 2026-07-15 | $58.95 |
| 2026-07-14 | $58.64 |
| 2026-07-13 | $59.20 |
| 2026-07-10 | $59.12 |
| 2026-07-09 | $59.97 |
| 2026-07-08 | $59.75 |
| 2026-07-07 | $60.35 |
| 2026-07-06 | $58.79 |
| 2026-07-02 | $58.99 |
| 2026-07-01 | $57.82 |
| 2026-06-30 | $57.22 |
| 2026-06-29 | $57.67 |
| 2026-06-26 | $59.00 |
| 2026-06-25 | $57.35 |
| 2026-06-24 | $57.33 |
| 2026-06-23 | $56.50 |
| 2026-06-22 | $55.90 |
| 2026-06-18 | $54.69 |
| 2026-06-17 | $55.02 |
| 2026-06-16 | $55.12 |
| 2026-06-15 | $55.65 |
| 2026-06-12 | $55.95 |
| 2026-06-11 | $55.54 |
| 2026-06-10 | $56.17 |
| 2026-06-09 | $57.91 |
| 2026-06-08 | $56.55 |
| 2026-06-05 | $56.77 |
| 2026-06-04 | $56.47 |
| 2026-06-03 | $54.66 |
| 2026-06-02 | $53.32 |
| 2026-06-01 | $55.03 |
| 2026-05-29 | $57.29 |
| 2026-05-28 | $52.74 |
| 2026-05-27 | $52.38 |
| 2026-05-26 | $52.88 |
| 2026-05-22 | $54.09 |
| 2026-05-21 | $54.10 |
| 2026-05-20 | $50.20 |
| 2026-05-19 | $49.81 |
| 2026-05-18 | $49.67 |
| 2026-05-15 | $51.81 |
| 2026-05-14 | $53.24 |
| 2026-05-13 | $53.55 |
| 2026-05-12 | $52.88 |
| 2026-05-11 | $52.58 |
| 2026-05-08 | $54.06 |
| 2026-05-07 | $54.12 |
| 2026-05-06 | $54.60 |
| 2026-05-05 | $53.24 |
| 2026-05-04 | $55.46 |
| 2026-05-01 | $54.06 |
| 2026-04-30 | $53.91 |
| 2026-04-29 | $54.21 |
| 2026-04-28 | $53.30 |